Disease Type - Transthyretin Amyloidosis Treatment Market Statistics

The global disease type transthyretin amyloidosis treatment market size was valued at US$ 6,644.3 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2030.

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global transthyretin amyloidosis treatment market statistics, 2018-2030 (US$M)

Global transthyretin amyloidosis treatment market statistics, 2018-2030 (US$M)

Transthyretin Amyloidosis Treatment Market Scope

Transthyretin amyloidosis treatment market segmentation & scope
Onpattro
Amvuttra
Wainua
Tegsedi
Vyndaqel/ Vyndamax
Supportive Therapy
Pipeline Therapy
ATTR with Polyneuropathy (ATTR-PN)
ATTR with Cardiomyopathy (ATTR-CM)
Wild Type Amyloidosis
Mixed Type
Cardiomyopathy
Polyneuropathy
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Pharmacies
report
Transthyretin Amyloidosis Treatment Market Outlook
  • PDF
  • HTML
  • PPT
  • -
Everything on Transthyretin Amyloidosis Treatment Market Outlook in one document: edited and divided into chapters, including detailed references.

Related Regional Reports

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more